Stem memory T cells (TSCM)-their role in cancer and HIV immunotherapies
- PMID: 25505968
- PMCID: PMC4232066
- DOI: 10.1038/cti.2014.16
Stem memory T cells (TSCM)-their role in cancer and HIV immunotherapies
Abstract
Stem memory T cells (TSCM) have been described in mice, non-human primates and in humans, constituting approximately 2-4% of the total CD4(+) and CD8(+) T-cell population in the periphery. TSCM represent the earliest and long-lasting developmental stage of memory T cells, displaying stem cell-like properties, and exhibiting a gene profile between naïve and central memory T cells. Their self-renewal capacity and long-term survival has sparked interest in the cancer and human immunodeficiency virus (HIV) fields. How and when the formation of TSCM occurs during the immune response to pathogens and the therapeutic potential of these cells are currently being investigated. This review will explore the potential role of TSCM to be used as, or targeted by, immunotherapies and vaccines for treatment of cancer and HIV.
Figures
Similar articles
-
[Advances in the Role of Stem Memory T Cells in HIV-1 Infection].Bing Du Xue Bao. 2016 Nov;32(6):796-9. Bing Du Xue Bao. 2016. PMID: 30004654 Review. Chinese.
-
T cell therapies-are T memory stem cells the answer?Ann Transl Med. 2015 Oct;3(17):251. doi: 10.3978/j.issn.2305-5839.2015.08.13. Ann Transl Med. 2015. PMID: 26605297 Free PMC article.
-
CD4+ T Memory Stem Cells Correlate with Disease Progression in Chronically HIV-1-Infected Patients.Viral Immunol. 2017 Nov;30(9):642-648. doi: 10.1089/vim.2017.0017. Epub 2017 Oct 16. Viral Immunol. 2017. PMID: 29035156
-
Detection and Characterization of CD8+ Autoreactive Memory Stem T Cells in Patients With Type 1 Diabetes.Diabetes. 2018 May;67(5):936-945. doi: 10.2337/db17-1390. Epub 2018 Mar 5. Diabetes. 2018. PMID: 29506985
-
Stem cell like memory T cells: A new paradigm in cancer immunotherapy.Clin Immunol. 2022 Aug;241:109078. doi: 10.1016/j.clim.2022.109078. Epub 2022 Jul 15. Clin Immunol. 2022. PMID: 35840054 Review.
Cited by
-
Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors.Onco Targets Ther. 2018 Dec 24;12:193-204. doi: 10.2147/OTT.S190336. eCollection 2019. Onco Targets Ther. 2018. PMID: 30636882 Free PMC article. Review.
-
Unlocking the potential of T-cell metabolism reprogramming: Advancing single-cell approaches for precision immunotherapy in tumour immunity.Clin Transl Med. 2024 Mar;14(3):e1620. doi: 10.1002/ctm2.1620. Clin Transl Med. 2024. PMID: 38468489 Free PMC article. Review.
-
[Oxidized low-density lipoprotein modulates differentiation of murine memory CD8+ T cell subpopulations].Nan Fang Yi Ke Da Xue Xue Bao. 2017 Aug 20;37(8):1098-1103. doi: 10.3969/j.issn.1673-4254.2017.08.16. Nan Fang Yi Ke Da Xue Xue Bao. 2017. PMID: 28801292 Free PMC article. Chinese.
-
Drug and Chemical Allergy: A Role for a Specific Naive T-Cell Repertoire?Front Immunol. 2021 Jun 29;12:653102. doi: 10.3389/fimmu.2021.653102. eCollection 2021. Front Immunol. 2021. PMID: 34267746 Free PMC article. Review.
-
Chimeric antigen receptor-modified T cells strike back.Int Immunol. 2016 Jul;28(7):355-63. doi: 10.1093/intimm/dxw018. Epub 2016 Mar 28. Int Immunol. 2016. PMID: 27021308 Free PMC article. Review.
References
-
- Kalia V, Sarkar S, Ahmed R.CD8 T-cell memory differentiation during acute and chronic viral infectionsIn: Zanetti M, Schoenberger SP, (eds). Advances in Experimental Biology Landes Bioscience: Texas, USA; 2010. p79–95. - PubMed
-
- Gattinoni L, Restifo NP. Moving T memory stem cells to the clinic. Blood. 2013;121:567–578. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials